Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Otolaryngology | 14 | 2023 | 645 | 3.180 |
Why?
|
Cochlear Implantation | 8 | 2021 | 310 | 2.870 |
Why?
|
Otitis Media with Effusion | 4 | 2023 | 114 | 2.520 |
Why?
|
Hearing Loss, Sensorineural | 8 | 2022 | 770 | 2.420 |
Why?
|
Cochlear Implants | 7 | 2021 | 339 | 2.290 |
Why?
|
Neuroma, Acoustic | 4 | 2024 | 451 | 2.230 |
Why?
|
Hearing Loss | 6 | 2022 | 765 | 2.200 |
Why?
|
Hearing Aids | 2 | 2022 | 55 | 1.380 |
Why?
|
Tympanic Membrane | 2 | 2023 | 225 | 1.310 |
Why?
|
Lipoma | 3 | 2015 | 334 | 1.220 |
Why?
|
Meniere Disease | 3 | 2021 | 161 | 1.170 |
Why?
|
Vocal Cord Paralysis | 2 | 2019 | 267 | 1.030 |
Why?
|
Otitis Media | 3 | 2023 | 277 | 0.980 |
Why?
|
Hearing Tests | 5 | 2022 | 122 | 0.960 |
Why?
|
Hearing Loss, Sudden | 3 | 2021 | 43 | 0.960 |
Why?
|
Cerebellopontine Angle | 2 | 2014 | 55 | 0.920 |
Why?
|
Sleep Apnea, Central | 1 | 2023 | 84 | 0.830 |
Why?
|
Artificial Intelligence | 4 | 2023 | 2214 | 0.830 |
Why?
|
Vestibular Diseases | 3 | 2021 | 217 | 0.780 |
Why?
|
Otorhinolaryngologic Diseases | 2 | 2019 | 90 | 0.770 |
Why?
|
Middle Ear Ventilation | 2 | 2021 | 94 | 0.730 |
Why?
|
Otitis Externa | 2 | 2016 | 19 | 0.720 |
Why?
|
Speech Perception | 2 | 2022 | 489 | 0.650 |
Why?
|
Cerebellar Neoplasms | 2 | 2014 | 587 | 0.640 |
Why?
|
Brain Stem | 2 | 2014 | 846 | 0.630 |
Why?
|
Mastoiditis | 1 | 2018 | 34 | 0.630 |
Why?
|
Equipment Failure Analysis | 1 | 2020 | 868 | 0.610 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2020 | 139 | 0.610 |
Why?
|
Hemangioma, Capillary | 1 | 2017 | 61 | 0.570 |
Why?
|
Ear Neoplasms | 1 | 2017 | 117 | 0.560 |
Why?
|
Second-Look Surgery | 1 | 2016 | 29 | 0.560 |
Why?
|
Eustachian Tube | 1 | 2017 | 91 | 0.540 |
Why?
|
Cholesteatoma, Middle Ear | 1 | 2016 | 49 | 0.540 |
Why?
|
Databases, Factual | 13 | 2021 | 7729 | 0.540 |
Why?
|
Tympanoplasty | 1 | 2016 | 71 | 0.540 |
Why?
|
Internet | 2 | 2020 | 3064 | 0.540 |
Why?
|
Community Networks | 1 | 2017 | 203 | 0.530 |
Why?
|
Microcomputers | 1 | 2015 | 147 | 0.530 |
Why?
|
Pharyngeal Neoplasms | 1 | 2015 | 117 | 0.520 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2020 | 329 | 0.520 |
Why?
|
Corynebacterium | 1 | 2015 | 47 | 0.510 |
Why?
|
Corynebacterium Infections | 1 | 2015 | 27 | 0.510 |
Why?
|
Public Sector | 1 | 2017 | 265 | 0.510 |
Why?
|
Thoracic Surgical Procedures | 1 | 2019 | 342 | 0.510 |
Why?
|
Hearing Loss, Conductive | 1 | 2016 | 158 | 0.500 |
Why?
|
Sleep Apnea Syndromes | 1 | 2023 | 944 | 0.500 |
Why?
|
Esophagectomy | 1 | 2018 | 447 | 0.500 |
Why?
|
Osseointegration | 1 | 2016 | 276 | 0.490 |
Why?
|
Triage | 1 | 2021 | 976 | 0.490 |
Why?
|
North Carolina | 4 | 2020 | 315 | 0.470 |
Why?
|
Tonsillectomy | 1 | 2017 | 255 | 0.470 |
Why?
|
Retirement | 1 | 2015 | 215 | 0.470 |
Why?
|
Vocal Cords | 1 | 2018 | 528 | 0.470 |
Why?
|
Private Sector | 1 | 2017 | 392 | 0.460 |
Why?
|
Dizziness | 3 | 2023 | 251 | 0.450 |
Why?
|
Deglutition Disorders | 1 | 2019 | 605 | 0.450 |
Why?
|
Diuretics | 1 | 2016 | 592 | 0.440 |
Why?
|
Academic Medical Centers | 4 | 2015 | 2759 | 0.430 |
Why?
|
Sarcoma, Synovial | 1 | 2014 | 167 | 0.430 |
Why?
|
Humans | 72 | 2024 | 744343 | 0.420 |
Why?
|
Health Resources | 1 | 2018 | 911 | 0.410 |
Why?
|
Hospital Administration | 1 | 2015 | 353 | 0.410 |
Why?
|
Writing | 1 | 2013 | 206 | 0.390 |
Why?
|
Efficiency, Organizational | 1 | 2015 | 695 | 0.380 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5319 | 0.370 |
Why?
|
Costs and Cost Analysis | 1 | 2016 | 1681 | 0.360 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2023 | 1813 | 0.360 |
Why?
|
Retrospective Studies | 24 | 2023 | 77449 | 0.350 |
Why?
|
Microsurgery | 1 | 2015 | 796 | 0.350 |
Why?
|
Drainage | 1 | 2015 | 1142 | 0.350 |
Why?
|
Wounds and Injuries | 1 | 2022 | 2400 | 0.340 |
Why?
|
Population Surveillance | 1 | 2020 | 2616 | 0.340 |
Why?
|
Hypersensitivity | 1 | 2017 | 1102 | 0.320 |
Why?
|
Patient Acceptance of Health Care | 1 | 2022 | 3022 | 0.310 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 7181 | 0.300 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1177 | 0.290 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1790 | 0.290 |
Why?
|
Publishing | 1 | 2013 | 833 | 0.270 |
Why?
|
Adult | 24 | 2022 | 214055 | 0.270 |
Why?
|
Postoperative Complications | 2 | 2018 | 15295 | 0.270 |
Why?
|
Ear Diseases | 2 | 2018 | 170 | 0.270 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1637 | 0.270 |
Why?
|
Teaching | 1 | 2013 | 1174 | 0.260 |
Why?
|
Health Services Accessibility | 3 | 2017 | 5137 | 0.250 |
Why?
|
Algorithms | 6 | 2023 | 13881 | 0.250 |
Why?
|
Male | 29 | 2023 | 350118 | 0.240 |
Why?
|
Otoscopy | 2 | 2021 | 36 | 0.240 |
Why?
|
Child | 14 | 2023 | 77709 | 0.240 |
Why?
|
Female | 30 | 2023 | 380194 | 0.240 |
Why?
|
Canada | 3 | 2021 | 2065 | 0.230 |
Why?
|
Aged, 80 and over | 10 | 2022 | 57776 | 0.230 |
Why?
|
Seasons | 2 | 2022 | 1493 | 0.230 |
Why?
|
Air Pressure | 1 | 2023 | 75 | 0.220 |
Why?
|
Quality of Life | 4 | 2021 | 12804 | 0.220 |
Why?
|
Medicaid | 1 | 2016 | 2736 | 0.220 |
Why?
|
Health Care Costs | 1 | 2016 | 3209 | 0.220 |
Why?
|
Electronic Health Records | 3 | 2021 | 4468 | 0.220 |
Why?
|
Registries | 1 | 2018 | 8089 | 0.220 |
Why?
|
Aged | 16 | 2023 | 163280 | 0.210 |
Why?
|
Immunotherapy | 1 | 2017 | 4445 | 0.200 |
Why?
|
Depression | 1 | 2021 | 7766 | 0.200 |
Why?
|
Vertigo | 1 | 2023 | 202 | 0.200 |
Why?
|
Adolescent | 13 | 2018 | 85781 | 0.190 |
Why?
|
Middle Aged | 19 | 2023 | 213383 | 0.190 |
Why?
|
United States | 10 | 2022 | 69872 | 0.190 |
Why?
|
Students, Medical | 1 | 2013 | 1862 | 0.180 |
Why?
|
Voice | 1 | 2023 | 259 | 0.180 |
Why?
|
Voice Disorders | 1 | 2023 | 276 | 0.180 |
Why?
|
Sex Reassignment Procedures | 1 | 2020 | 50 | 0.180 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2023 | 312 | 0.180 |
Why?
|
Cost-Benefit Analysis | 3 | 2017 | 5391 | 0.180 |
Why?
|
Audiometry | 1 | 2020 | 241 | 0.180 |
Why?
|
Intraoperative Period | 1 | 2021 | 520 | 0.180 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2734 | 0.180 |
Why?
|
Health Personnel | 1 | 2013 | 3218 | 0.180 |
Why?
|
Disease Notification | 1 | 2020 | 97 | 0.170 |
Why?
|
Forecasting | 2 | 2020 | 2951 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 5 | 2024 | 35421 | 0.170 |
Why?
|
Hyperplasia | 1 | 2022 | 1185 | 0.170 |
Why?
|
Voice Quality | 1 | 2020 | 217 | 0.160 |
Why?
|
Empty Sella Syndrome | 1 | 2018 | 14 | 0.160 |
Why?
|
Nose | 1 | 2022 | 509 | 0.160 |
Why?
|
Treatment Outcome | 11 | 2023 | 63114 | 0.160 |
Why?
|
Noise | 1 | 2020 | 279 | 0.160 |
Why?
|
Urban Population | 2 | 2017 | 2021 | 0.160 |
Why?
|
Ergolines | 1 | 2018 | 61 | 0.160 |
Why?
|
Nutrition Surveys | 2 | 2023 | 1660 | 0.160 |
Why?
|
Optic Chiasm | 1 | 2018 | 87 | 0.150 |
Why?
|
Neck | 1 | 2022 | 697 | 0.150 |
Why?
|
Tinnitus | 1 | 2020 | 195 | 0.150 |
Why?
|
Prolactinoma | 1 | 2018 | 113 | 0.150 |
Why?
|
Physicians | 1 | 2015 | 4567 | 0.150 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11727 | 0.150 |
Why?
|
Polymyxin B | 1 | 2016 | 46 | 0.150 |
Why?
|
Neomycin | 1 | 2016 | 88 | 0.140 |
Why?
|
Ofloxacin | 1 | 2016 | 65 | 0.140 |
Why?
|
Head | 1 | 2022 | 880 | 0.140 |
Why?
|
Child, Preschool | 7 | 2018 | 41006 | 0.140 |
Why?
|
Vestibular Function Tests | 1 | 2016 | 127 | 0.140 |
Why?
|
Rural Population | 2 | 2017 | 2210 | 0.140 |
Why?
|
Mastoid | 1 | 2016 | 92 | 0.130 |
Why?
|
Mouth Neoplasms | 1 | 2021 | 601 | 0.130 |
Why?
|
Administration, Intranasal | 1 | 2017 | 446 | 0.130 |
Why?
|
Tympanic Membrane Perforation | 1 | 2015 | 41 | 0.130 |
Why?
|
State Medicine | 1 | 2017 | 217 | 0.130 |
Why?
|
Decision Trees | 1 | 2017 | 506 | 0.130 |
Why?
|
Mexican Americans | 1 | 2016 | 166 | 0.130 |
Why?
|
Dopamine Agonists | 1 | 2018 | 355 | 0.130 |
Why?
|
Headache | 1 | 2023 | 1226 | 0.130 |
Why?
|
Infant | 7 | 2021 | 35136 | 0.130 |
Why?
|
Incidence | 3 | 2018 | 20947 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6538 | 0.120 |
Why?
|
Cytomegalovirus Infections | 1 | 2021 | 820 | 0.120 |
Why?
|
Recurrence | 2 | 2017 | 8340 | 0.120 |
Why?
|
Ciprofloxacin | 1 | 2016 | 315 | 0.120 |
Why?
|
Physicians, Primary Care | 1 | 2021 | 591 | 0.120 |
Why?
|
Young Adult | 8 | 2018 | 56430 | 0.120 |
Why?
|
Health Services Research | 3 | 2016 | 1836 | 0.120 |
Why?
|
International Classification of Diseases | 2 | 2016 | 867 | 0.120 |
Why?
|
Insurance, Health | 2 | 2017 | 2494 | 0.120 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2017 | 397 | 0.120 |
Why?
|
Poverty Areas | 1 | 2015 | 275 | 0.120 |
Why?
|
Comorbidity | 2 | 2018 | 10388 | 0.120 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2021 | 1770 | 0.110 |
Why?
|
Administration, Topical | 1 | 2015 | 690 | 0.110 |
Why?
|
Neoplasms | 1 | 2022 | 21683 | 0.110 |
Why?
|
Fluoroquinolones | 1 | 2015 | 310 | 0.110 |
Why?
|
Prosthesis Implantation | 1 | 2018 | 642 | 0.110 |
Why?
|
Insurance Claim Review | 1 | 2017 | 720 | 0.110 |
Why?
|
Neck Dissection | 1 | 2014 | 197 | 0.110 |
Why?
|
Semicircular Canals | 1 | 2014 | 198 | 0.110 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1584 | 0.110 |
Why?
|
Prevalence | 3 | 2018 | 15226 | 0.100 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2020 | 1534 | 0.100 |
Why?
|
Bayes Theorem | 1 | 2020 | 2309 | 0.100 |
Why?
|
Health Care Surveys | 2 | 2016 | 2453 | 0.100 |
Why?
|
Cleft Palate | 1 | 2017 | 560 | 0.100 |
Why?
|
Watchful Waiting | 1 | 2015 | 492 | 0.100 |
Why?
|
Drug Combinations | 1 | 2016 | 1959 | 0.100 |
Why?
|
Quality Indicators, Health Care | 1 | 2021 | 1831 | 0.100 |
Why?
|
Postoperative Period | 1 | 2016 | 1842 | 0.090 |
Why?
|
Guideline Adherence | 1 | 2021 | 2266 | 0.090 |
Why?
|
Rare Diseases | 1 | 2015 | 553 | 0.090 |
Why?
|
Drugs, Generic | 1 | 2015 | 421 | 0.090 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1772 | 0.090 |
Why?
|
Biopsy | 1 | 2022 | 6756 | 0.090 |
Why?
|
Infant, Newborn | 4 | 2021 | 25625 | 0.090 |
Why?
|
Workload | 1 | 2015 | 850 | 0.090 |
Why?
|
Medically Uninsured | 1 | 2015 | 853 | 0.090 |
Why?
|
Temporal Bone | 1 | 2014 | 661 | 0.090 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1345 | 0.080 |
Why?
|
Dexamethasone | 1 | 2016 | 1951 | 0.080 |
Why?
|
Microbial Sensitivity Tests | 1 | 2015 | 1877 | 0.080 |
Why?
|
Age Factors | 2 | 2016 | 18370 | 0.080 |
Why?
|
Down Syndrome | 1 | 2017 | 880 | 0.080 |
Why?
|
Hydrocortisone | 1 | 2016 | 1826 | 0.080 |
Why?
|
Referral and Consultation | 2 | 2021 | 3528 | 0.080 |
Why?
|
Reoperation | 1 | 2018 | 4201 | 0.080 |
Why?
|
Medicare | 2 | 2016 | 6566 | 0.080 |
Why?
|
Endoscopy | 1 | 2017 | 1785 | 0.070 |
Why?
|
Hearing | 2 | 2021 | 482 | 0.070 |
Why?
|
Quality Improvement | 2 | 2021 | 3749 | 0.070 |
Why?
|
Exercise | 1 | 2023 | 5615 | 0.070 |
Why?
|
Sex Factors | 2 | 2020 | 10397 | 0.070 |
Why?
|
Preoperative Care | 1 | 2015 | 2250 | 0.070 |
Why?
|
Lumbar Vertebrae | 1 | 2015 | 1848 | 0.070 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3616 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2014 | 3479 | 0.070 |
Why?
|
Logistic Models | 1 | 2020 | 13408 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2016 | 2708 | 0.060 |
Why?
|
Risk Assessment | 2 | 2019 | 23338 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6309 | 0.060 |
Why?
|
Pandemics | 2 | 2021 | 8388 | 0.060 |
Why?
|
Inpatients | 1 | 2015 | 2518 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3610 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12354 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6895 | 0.060 |
Why?
|
Cohort Studies | 2 | 2017 | 40561 | 0.060 |
Why?
|
Telemedicine | 1 | 2020 | 2872 | 0.050 |
Why?
|
Risk Factors | 3 | 2019 | 72290 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Prospective Studies | 2 | 2017 | 53288 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14722 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8642 | 0.050 |
Why?
|
Ischemia | 1 | 2010 | 1907 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2017 | 13989 | 0.050 |
Why?
|
Survival Analysis | 1 | 2014 | 10252 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25043 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39050 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2018 | 21746 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11031 | 0.040 |
Why?
|
Communication | 1 | 2013 | 3749 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2010 | 3508 | 0.040 |
Why?
|
Eye | 1 | 2023 | 729 | 0.040 |
Why?
|
Computational Biology | 1 | 2010 | 3521 | 0.040 |
Why?
|
Myocardium | 1 | 2010 | 4776 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2010 | 5021 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2021 | 732 | 0.040 |
Why?
|
Neonatal Screening | 1 | 2021 | 591 | 0.040 |
Why?
|
Operating Rooms | 1 | 2023 | 817 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5853 | 0.030 |
Why?
|
ROC Curve | 1 | 2023 | 3527 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4931 | 0.030 |
Why?
|
Time Factors | 1 | 2017 | 40075 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5535 | 0.030 |
Why?
|
Prognosis | 1 | 2014 | 29063 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2124 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20129 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1855 | 0.030 |
Why?
|
Transcription Factors | 1 | 2010 | 12208 | 0.020 |
Why?
|
Haplorhini | 1 | 2010 | 552 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2010 | 1581 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 905 | 0.020 |
Why?
|
Animals | 2 | 2017 | 168757 | 0.020 |
Why?
|
Immunoblotting | 1 | 2010 | 1682 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2002 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5078 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19905 | 0.010 |
Why?
|
Phylogeny | 1 | 2010 | 2803 | 0.010 |
Why?
|
Protein Kinases | 1 | 2010 | 1640 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 7023 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12959 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 8301 | 0.010 |
Why?
|
Protein Binding | 1 | 2010 | 9386 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11366 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15997 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2010 | 7913 | 0.010 |
Why?
|
Rats | 1 | 2010 | 24260 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9648 | 0.010 |
Why?
|
Mice | 1 | 2010 | 81183 | 0.000 |
Why?
|
Concepts
(272)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(41)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_